Pregnancy Testing Market By Product Type (Line pregnancy tests {Test cassette format, Test strip format, Test midstream format}, Digital devices, Others), By Test Type (Urine test for HCG, Blood test for HCG), By End User (Hospitals and maternity clinics, Home care setting and others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

Pregnancy Testing market accounted for USD 1.75 Billion in 2024 and is expected to reach USD 3.25 Billion by 2035, growing at a CAGR of around 5.8% between 2025 and 2035. The pregnancy testing market includes the production, distribution, and sale of pregnancy test kits. In this sector, there are mainly two types of tests home pregnancy tests, which are usually bought over-the-counter and utilize urine samples, and clinical pregnancy tests, which are done under the supervision of healthcare providers using blood samples. The increase in awareness regarding reproductive health, coupled with improved accuracy and user-friendly methods, has contributed to increased growth of the market. Digital tests as well as apps for tracking ovulation and fertility have resulted in its expansion.

Report Scope:

Market Dynamics

Advancements in non-invasive testing methods offer potential for market expansion.

The advancement of non-invasive testing methods is driving the pregnancy testing market. Innovations produce highly accurate, convenient, and less intrusive early detection and look for consumers' comfort and privacy. In addition, people are aware of reproductive health and stimulating demand for over-the-counter testing products that enhance market adoption.

According to a 2023 Guttmacher Institute report, nearly 45% of pregnancies in the US are unintended, highlighting the need for easy-to-use pregnancy tests. Mobile app-integrated with pregnancy tests are helping users monitor their results and personal health information.

Issues with test accuracy may lead to consumer distrust and hesitation.

Inaccuracy of test results poses a major restraint for the pregnancy testing market as it affects directly customer confidence as well as their inclination towards using these items. Pregnancy tests make critical decisions about reproductive health, and wrong results like false positives or negatives lead to customer dissatisfaction. Such inaccuracies can trigger unnecessary panic or a loss of a chance for prenatal care at an early stage.

A recent report by the FDA states that 10–15 percent of home pregnancy kits may produce false readings, causing inconsistency that influences the consumers’ level of trust. Continuous improvements are needed because of regulatory concerns and customers’ demand for more reliable, transparent testing. Consequently, there is pressure on manufacturers to improve their product’s accuracy and transparency to restore and maintain confidence among users in their products.

Incorporating digital features like app integration enhances user experience and data management.

There is an opportunity for growth in the pregnancy testing market by incorporating digital features such as app integration. Ovulation tests are already popular with consumers trying to conceive, so adding this feature to the pregnancy test will draw in an even wider audience. A dual-function pregnancy test not only confirms pregnancy but also provides detailed information on ovulation cycles. These apps are useful to customers and will make them more engaged and loyal, as they can use or acquire the more comprehensive aspect of the test as a family planning or health monitoring device. Additionally, this may increase market share and open up new product lines and partnership opportunities for the business. This initiative fits perfectly with the trend of consumer interest and demand for multifunction health products and personalized medical data insights.

Industry Experts Opinion

“Ovulation kits measure the amount of luteinizing hormone (LH) in your urine. LH surges sometime between 24 and 36 hours before ovulation, so detecting that rise can help you predict when you’re most likely to be able to conceive.”

-Katrina Heyrana, M.D., PhD, a specialist in obstetrics and gynecology at Cedars Sinai in Los Angeles

 “Pregnancy tests detect a hormone called human Chorionic Gonadotropin (hCG), which can be detected in urine or blood after an embryo implants itself into your uterine wall,”

- Dr.Kenosa Gleaton,MD obstetrician-gynecologist in Charleston,

Segment Analysis

Based on the product type, the Pregnancy Testing market has been classified into Line pregnancy tests (Test cassette format, Test strip format, Test midstream format), Digital devices, and Others. The line pregnancy tests are the most dominant segment in the pregnancy testing market. The test strip format is available at a low price. Its user independence and high degree of reliability are some of the reasons for making it widely accepted by many people. These strips can simply be put in a urine sample, and the results read as changes in color, which makes it easy for users to know whether they are pregnant or not. With its simpler nature, the test strip format eliminates the need for applying complex technologies.

Based on the test type, the Pregnancy Testing market has been classified into Urine tests for HCG and blood tests for HCG. In the pregnancy testing market, the urine test for human chorionic gonadotropin (HCG) is the most prominent and significant segment. Urine tests are preferred because they are affordable and easy to use. Hence, one can do them privately at home without medical assistance. These tests have accurate results since they assess urine samples to determine if there is HCG present, this hormone is produced during pregnancy. Most of these kits come in the form of sticks or dip strips, which would give a result within minutes. Their availability from chemists, along with privacy considerations, have made them popular among end users.

Regional Analysis

In North America, the pregnancy testing market is witnessing rapid growth due to increasing technological advancements in pregnancy tests. This market consists of various testing products, from conventional urine-based tests to more sophisticated digital or early pregnancy tests. There is a need for accurate and accessible tests in this region because awareness, knowledge, and access to healthcare are high. Major contributors to this market are key players who are always trying to include new innovative features like digital readouts and app connectivity, among others.

The Asia Pacific pregnancy testing market is experiencing significant growth as a result of increased awareness about reproductive health as well as increasing spending on healthcare. This area has different demography and disease patterns, which affect the market differently from one country to another. In developed countries such as Japan and Australia, advanced testing technologies coupled with high-income levels drive the market, whereas, in developing nations like India and China, rising awareness coupled with improvements in health systems will facilitate this growth process.

Competitive Landscape

The pregnancy testing market is highly competitive, having major players like Procter & Gamble Co., Church & Dwight Co., Inc., Abbott Laboratories, and Quidel Corporation. The recent developments in the sector show continuous innovation and adjustment to what customers want. Procter & Gamble launched new digital pregnancy tests that connect to smartphones, thus increasing convenience for users while making sure that results are accurate. Abbott Laboratories has introduced a new pregnancy test that is easy to use with quick results. Notably, Quidel Corporation has directed its energy towards integrating high technology into diagnostic tests to make them more reliable and convenient for people to use.

Pregnancy Testing Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In May 2024, Abingdon Health plc (AIM: ABDX), a leading worldwide lateral flow contract development and manufacturing organization (CDMO), announced the online launch of Boots' exclusive saliva pregnancy self-test in partnership with Salignostics and Crest Medical.
• In September 2022, a non-invasive preimplantation genetic aneuploidy screening test (niPGT-A) was introduced by Eurofins Genoma to address the various diagnostic requirements in reproductive genetics and offer IVF centers a reliable substitute for conventional testing.

Report Coverage:

By Product Type

• Line pregnancy tests
  • Test cassette format
  • Test strip format
  • Test midstream format
• Digital devices
• Others

By Test Type

• Urine test for HCG
• Blood test for HCG

By End User

• Hospitals and maternity clinics
• Home care setting
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Procter & Gamble Co. 
• Church & Dwight Co., Inc. 
• Abbott Laboratories 
• Quidel Corporation 
• BD (Becton, Dickinson, and Company) 
• i-Health, Inc. 
• Geratherm Medical AG 
• Mylan N.V. 
• Fertility Focus Ltd. 
• BioCheck, Inc. 
• AccuBioTech Co., Ltd 
• Hologic, Inc. 
• SonaCare Medical 
• Watson Pharmaceuticals, Inc. 
• Alere Inc.

Frequently Asked Questions (FAQs)